1-7 of 7
hematologic agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Examining Convergent Construct Validity and Inter-Rater Reliability Between ESMO-MCBS and ASCO-VF When Evaluating Hematologic Malignancies

Matthew Cheung, MD MS, FRCP, Ihsan Albakri, Robert Mason, Ronak Saluja, Sierra Cheng, Vanessa Arciero, Louis Everest, Kelvin Chan, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4800.
https://doi.org/10.1182/blood-2018-99-119631
Published: 2018
Journal Articles

Farrell AT, Goldberg KB, Pazdur R. Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs. Blood. 2017;130(11):1285-1289.

Journal: Blood
Blood (2018) 131 (16): 1875–1876.
https://doi.org/10.1182/blood-2018-02-836916
Published: 2018
Journal Articles

Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia

Stephen Yang Liang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3227.
https://doi.org/10.1182/blood.V130.Suppl_1.3227.3227
Published: 2017
Journal Articles

Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs

Clinical Trials & Observations
Ann T. Farrell, Kirsten B. Goldberg, Richard Pazdur
Journal: Blood
Blood (2017) 130 (11): 1285–1289.
https://doi.org/10.1182/blood-2017-04-742726
Published: 2017
Journal Articles

Propylene Glycol-Free Melphalan Induces Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation

Omar S. Aljitawi, MD, Anna Ludlow, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Tara Lin, MD, J.D Pipkin, PhD, Joseph McGuirk, DO
Journal: Blood
Blood (2012) 120 (21): 4551.
https://doi.org/10.1182/blood.V120.21.4551.4551
Published: 2012
Journal Articles

Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan HCl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Omar S. Aljitawi, MD, Sunil Abhyankar, MD, Siddhartha Ganguly, MD, Karen Wolfe, Kelly Daniels, Ron Marks, Mike Ferree, J.D. Pipkin, PhD, Joseph McGuirk, DO
Journal: Blood
Blood (2011) 118 (21): 4512.
https://doi.org/10.1182/blood.V118.21.4512.4512
Published: 2011
Journal Articles

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Charles V. Wendling, MD, Jonathan Glass, MD, Perry G. Rigby, MD
Journal: Blood
Blood (2006) 108 (11): 5491.
https://doi.org/10.1182/blood.V108.11.5491.5491
Published: 2006